# HTR5A

## Overview
The HTR5A gene encodes the 5-hydroxytryptamine receptor 5A, a G protein-coupled receptor (GPCR) that plays a pivotal role in the modulation of neurotransmission and various physiological processes within the central nervous system. This receptor, categorized as a serotonin receptor, is integral to the serotonin signaling pathways, influencing cognitive functions, emotional regulation, and circadian rhythms. The protein itself is characterized by a classic GPCR structure with seven transmembrane helices and is involved in complex interactions with G proteins and other signaling molecules, which facilitate a wide range of cellular responses (Barnes2020International). Genetic and functional studies of HTR5A have linked it to various psychiatric conditions and have highlighted its potential as a target for therapeutic interventions (Zhang2010Serotonin).

## Structure
The human 5-hydroxytryptamine receptor 5A (HTR5A) is a G protein-coupled receptor (GPCR) characterized by a classic GPCR structure with seven transmembrane helices. This receptor is involved in various physiological and psychological processes and has been a target for drug development. The primary structure of HTR5A consists of 357 amino acids in humans, mice, and rats, and 356 amino acids in guinea pigs (Barnes2020International). 

The receptor features several key structural domains and motifs that are crucial for its function. Notably, the transmembrane helices (TM4 and TM5) exhibit unique structural features such as bending and kinking, which are significant for receptor activation and interaction with G proteins (Zhang2022Inactive). The intracellular loops and the extracellular N-terminus are also important for receptor functionality, with the N-terminus containing N-linked glycosylation sites that could affect receptor expression and function (Barnes2020International).

Post-translational modifications include phosphorylation, which likely plays a role in agonist-induced downregulation, as indicated by the presence of consensus phosphorylation sites for protein kinase C and protein kinase A (Barnes2020International). Additionally, the receptor undergoes various conformational changes upon activation, involving movements of the transmembrane helices and specific microswitches such as the CWxP and PIF motifs (Zhang2022Inactive).

Overall, the molecular structure of HTR5A, including its primary, secondary, and tertiary structures, along with post-translational modifications, provides a foundation for understanding its function and interaction with ligands and transducers.

## Function
The HTR5A gene encodes the 5-hydroxytryptamine receptor 5A, a G protein-coupled receptor (GPCR) involved in various neurological and physiological processes. This receptor is primarily expressed in the central nervous system, including regions such as the cerebral cortex, hippocampus, and amygdala, where it plays a crucial role in neurotransmission and cellular signaling (Barnes2020International). The 5-HT5A receptor modulates the activity of ion channels and inhibits the basal activity of adenylyl cyclase, thereby reducing the formation of cAMP in response to stimuli. This modulation affects neuronal excitability and signaling in the prefrontal cortex, influencing cognitive functions and behavior (Barnes2020International).

Additionally, the 5-HT5A receptor has been implicated in the regulation of circadian rhythms and metabolism, as well as in emotional regulation and pain perception. Its role in pain management is particularly noted in the spinal cord where it contributes to antinociceptive processes (Barnes2020International). Genetic variations in the HTR5A gene have been associated with psychiatric conditions such as schizophrenia and depression, highlighting its significance in mental health (Barnes2020International). 

Overall, the HTR5A gene and its encoded protein are integral to maintaining various aspects of neurological function and behavioral responses through their involvement in serotonin-mediated signaling pathways.

## Clinical Significance
HTR5A, encoding the serotonin type 5A receptor, has been implicated in various psychiatric and metabolic conditions due to mutations or alterations in its expression. In schizophrenia, variations in the HTR5A gene, such as promoter SNPs, influence DNA methylation and transcription factor binding, affecting gene expression and potentially impacting cognitive functions in patients (Hrovatin2019Genetic). This gene is also associated with other psychiatric disorders including autism, mood disorders, and sleep disturbances, suggesting a broad role in mental health (Zhang2010Serotonin).

Moreover, HTR5A has been linked to metabolic regulation, particularly influencing plasma triglyceride levels. Studies have identified sequence variants in HTR5A that are strongly associated with high plasma triglyceride levels in individuals of Northern European descent, indicating a novel role for this serotonin receptor in metabolic processes (Zhang2010Serotonin). These findings suggest that HTR5A could indirectly affect conditions related to lipid metabolism, such as obesity or diabetes, though direct connections have not been conclusively demonstrated (Zhang2010Serotonin). 

Overall, the clinical significance of HTR5A spans both neuropsychiatric and metabolic domains, highlighting its potential as a target for therapeutic interventions in these areas.

## Interactions
The human 5-hydroxytryptamine receptor 5A (HTR5A) engages in significant physical interactions with various proteins, crucial for its function as a G protein-coupled receptor (GPCR). Notably, HTR5A interacts with the miniGo protein, a component of the G protein complex. This interaction is characterized by the engagement of the Î±5 helix region of miniGo with the HTR5A receptor, involving several hydrophilic interactions such as salt bridges and hydrogen bonds, as well as hydrophobic interactions forming a hydrophobic cavity (Zhang2022Inactive). Additionally, the ICL2 region of HTR5A plays a pivotal role, with specific residues inserting into a hydrophobic pocket of miniGo, which is essential for the activation of Gi protein signaling (Zhang2022Inactive).

In the active state, the receptor is coupled with the canonical transducer Go in complex with different agonists, highlighting the receptor's versatility in forming multiprotein complexes essential for signal transduction (Zhang2022Inactive). The interaction details include the outward tilt of TM6 and the inward shift of TM7, facilitating the coupling with the G protein, which underscores the direct physical interaction between HTR5A and G protein components (Zhang2022Inactive). These interactions are critical for the receptor's function in neurotransmission and its involvement in various physiological and psychological processes.


## References


[1. (Zhang2022Inactive) Shicheng Zhang, He Chen, Chengwei Zhang, Ying Yang, Petr Popov, Jing Liu, Brian E. Krumm, Can Cao, Kuglae Kim, Yan Xiong, Vsevolod Katritch, Brian K. Shoichet, Jian Jin, Jonathan F. Fay, and Bryan L. Roth. Inactive and active state structures template selective tools for the human 5-ht5a receptor. Nature Structural &amp; Molecular Biology, 29(7):677â687, July 2022. URL: http://dx.doi.org/10.1038/s41594-022-00796-6, doi:10.1038/s41594-022-00796-6. (17 citations) 10.1038/s41594-022-00796-6](https://doi.org/10.1038/s41594-022-00796-6)

[2. (Barnes2020International) Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, JoÃ«l Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, GhÃ©rici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. VillalÃ³n, Horst Vogel, Stephanie W. Watts, and Daniel Hoyer. International union of basic and clinical pharmacology. cx. classification of receptors for 5-hydroxytryptamine; pharmacology and function. Pharmacological Reviews, 73(1):310â520, December 2020. URL: http://dx.doi.org/10.1124/pr.118.015552, doi:10.1124/pr.118.015552. (146 citations) 10.1124/pr.118.015552](https://doi.org/10.1124/pr.118.015552)

[3. (Zhang2010Serotonin) Y. Zhang, E. M. Smith, T. M. Baye, J. V. Eckert, L. J. Abraham, E. K. Moses, A. H. Kissebah, L. J. Martin, and M. Olivier. Serotonin (5-ht) receptor 5a sequence variants affect human plasma triglyceride levels. Physiological Genomics, 42(2):168â176, July 2010. URL: http://dx.doi.org/10.1152/physiolgenomics.00038.2010, doi:10.1152/physiolgenomics.00038.2010. (31 citations) 10.1152/physiolgenomics.00038.2010](https://doi.org/10.1152/physiolgenomics.00038.2010)

[4. (Hrovatin2019Genetic) Karin Hrovatin, Tanja Kunej, and Vita DolÅ¾an. Genetic variability of serotonin pathway associated with schizophrenia onset, progression, and treatment. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 183(2):113â127, October 2019. URL: http://dx.doi.org/10.1002/ajmg.b.32766, doi:10.1002/ajmg.b.32766. (20 citations) 10.1002/ajmg.b.32766](https://doi.org/10.1002/ajmg.b.32766)